Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PF-07257876 |
Trade Name | |
Synonyms | PF 07257876|PF07257876 |
Drug Descriptions |
PF-07257876 is a bispecific antibody that targets CD47 and PD-L1 (CD274), which may lead to increased phagocytosis and enhanced cytotoxic T-lymphocyte (CTL) response against tumor cells expressing CD47 and PD-L1 (CD274) (NCI Thesaurus). |
DrugClasses | CD47 Antibody 31 PD-L1 Inhibitor 14 |
CAS Registry Number | NA |
NCIT ID | C180866 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
PF-07257876 | PF-07257876 | 1 | 1 |